References
- Bray F , FerlayJ, SoerjomataramIet al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin.68(6), 394–424 (2018).
- Gershman E , GuthrieR, SwiatekKet al. Management of hemoptysis in patients with lung cancer. Ann. Transl. Med.7(15), 358 (2019).
- Chung IH , ParkMH, KimDHet al. Endobronchial stent insertion to manage hemoptysis caused by lung cancer. J. Korean Med. Sci.25(8), 1253–1255 (2010).
- Hayakawa K , TanakaF, TorizukaTet al. Bronchial artery embolization for hemoptysis: immediate and long-term results. Cardiovasc. Intervent. Radiol.15(3), 154–158 (1992).
- Han K , YoonKW, KimJHet al. Bronchial artery embolization for hemoptysis in primary lung cancer: a retrospective review of 84 patients. J. Vasc. Interv. Radiol.30(3), 428–434 (2019).
- Cohen MJ , BloomAI, BarakOet al. Trans-arterial chemo-embolization is safe and effective for very elderly patients with hepatocellular carcinoma. World J. Gastroenterol.19(16), 2521–2528 (2013).
- Cucchetti A , TrevisaniF, CappelliAet al. Cost–effectiveness of doxorubicin-eluting beads versus conventional trans-arterial chemo-embolization for hepatocellular carcinoma. Dig. Liver Dis.48(7), 798–805 (2016).
- Chen Y , LiY, JiaYet al. Bronchial artery chemoembolization combined with radioactive iodine-125 seed implantation in the treatment of advanced nonsmall cell lung cancer. J. Cancer Res. Ther.13(4), 636–641 (2017).
- Bie Z , LiY, LiBet al. The efficacy of drug-eluting beads bronchial arterial chemoembolization loaded with gemcitabine for treatment of non-small cell lung cancer. Thorac. Cancer10(9), 1770–1778 (2019).
- Liu X , LinH, WangQet al. Drug-eluting beads bronchial arterial chemoembolization plus intercostals arterial infusion chemotherapy is effective and well-tolerated in treating non-small cell lung cancer patients with refractory malignant pleural effusion. J. Thorac. Dis.13(4), 2339–2350 (2021).
- Lin H , WangQ, TianFet al. Drug-eluting beads bronchial arterial chemoembolization in treating relapsed/refractory small cell lung cancer patients: results from a pilot study. Cancer Manag. Res.13, 6239–6248 (2021).
- Fu Z , GuoJ, HuangQet al. Efficacy and safety of drug-eluting beads bronchial arterial chemoembolization in treating patients with lung cancer who were complicated with hemoptysis. Cancer Biother. Radiopharm.doi:10.1089/cbr.2020.3954 (2020) ( Epub ahead of print).
- Boas FE , KemenyNE, SofocleousCTet al. Bronchial or pulmonary artery chemoembolization for unresectable and unablatable lung metastases: a phase I clinical trial. Radiology301(2), 474–484 (2021).
- Yu G , HuJ. Drug-eluting beads bronchial arterial chemoembolization as a neoadjuvant treatment for squamous non-small cell lung cancer. Postgrad. Med.132(6), 568–571 (2020).
- Shang B , LiJ, WangXet al. Clinical effect of bronchial arterial infusion chemotherapy and CalliSpheres drug-eluting beads in patients with stage II–IV lung cancer: a prospective cohort study. Thorac. Cancer11(8), 2155–2162 (2020).
- Liu J , ZhangW, RenJet al. Efficacy and safety of drug-eluting bead bronchial arterial chemoembolization plus anlotinib in patients with advanced non-small-cell lung cancer. Front. Cell. Dev. Biol.9, 768943 (2021).